Hi Monta, I see the FIRB has blocked the purchase (DOCA) of...

First 2348 Last

Share
Profile

Follow
Names little

19,346 Posts.

1474

21/07/23

21:33

Post #: 68919296
Share

Originally posted by Montalbano: ↑

China has the biggest REE resources in the world. China is the world's biggest (c. 85%) refiner of REE, into chemicals etc. for EV & renewables' storage batteries, & other renewable applications- & military & defence applications etc. It also has large, but declining, Li resources; & is also the biggest Li refiner.

China, taking advantage of its above dominance, has, for decades, also used economic coercion, bans, IP, patent & technology theft etc,. to further it economic & political ambitions.The latest was its 3.7.23 ban on export of many REE gallium & germanium products (which it also has dominance in).
See my link below.

https://www.news.com.au/finance/business/manufacturing/chinas-brute-force-plan-to-destroy-entire-industries-could-seriously-backfire/news-story/702c8b846aeae1b7293155609c129852

This will further reinforce the increasingly strong & publicly proclaimed belief by many western etc. countries that they must secure theircrucialsupply chains- particularly in Critical Minerals, refining, & processing. They have decided (eg US 2022 IR Act, & the EU 2023 Critical Materials legislation, & other programs), to investmuchmore in "friendly" countries in these Critical Minerals etc-to ensure the viability & success of the decarbonisation revolution...& for their own Defence needs.

China, which has increased its threats to invade Taiwan, is not trusted- & will very likely continue to use economic coercion against the West.

For Li & Li refining, these geopolitical factors bode very well for the success of the future owner of ESS (assuming it is not under majority Chinese ownership).

Expand

Hi Monta, I see the FIRB has blocked the purchase (DOCA) of Alita (with it's nearby Bald Hill mine) by China aligned interests.

Will add another piece into the puzzle of lithium M&A activity in the region, newspapers reporting it may be on the market within a month.

Last edited by Names little: 21/07/23

ESS Price at posting: 49.0¢ Sentiment: None Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 2348 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Hi Monta, I see the FIRB has blocked the purchase (DOCA) of...

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News